Alejandro Vallejo

2.8k total citations
101 papers, 1.7k citations indexed

About

Alejandro Vallejo is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, Alejandro Vallejo has authored 101 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Infectious Diseases, 45 papers in Virology and 36 papers in Immunology. Recurrent topics in Alejandro Vallejo's work include HIV Research and Treatment (44 papers), HIV/AIDS drug development and treatment (25 papers) and HIV/AIDS Research and Interventions (21 papers). Alejandro Vallejo is often cited by papers focused on HIV Research and Treatment (44 papers), HIV/AIDS drug development and treatment (25 papers) and HIV/AIDS Research and Interventions (21 papers). Alejandro Vallejo collaborates with scholars based in Spain, United States and Poland. Alejandro Vallejo's co-authors include Santiago Moreno, Nadia Madrid, Manuel Leal, Fernando Dronda, María Abad-Fernández, Carolina Gutiérrez, Sergio Serrano‐Villar, Natalia Soriano-Sarabia, Beatriz Hernández‐Novoa and Laura Díaz and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Alejandro Vallejo

98 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alejandro Vallejo Spain 20 766 744 417 383 368 101 1.7k
M. Leal Spain 24 599 0.8× 628 0.8× 318 0.8× 320 0.8× 674 1.8× 77 1.8k
Carol Harris United States 21 816 1.1× 473 0.6× 377 0.9× 393 1.0× 896 2.4× 41 2.4k
Don Smith Australia 28 1.5k 1.9× 1.4k 1.8× 815 2.0× 197 0.5× 865 2.4× 95 3.0k
Angela M. Amedee United States 26 842 1.1× 1.2k 1.7× 526 1.3× 214 0.6× 647 1.8× 65 2.1k
Jorge Carrillo Spain 29 715 0.9× 405 0.5× 577 1.4× 379 1.0× 377 1.0× 113 2.7k
Raphael B. Stricker United States 27 803 1.0× 440 0.6× 557 1.3× 133 0.3× 254 0.7× 110 2.3k
Priya Sehgal United States 19 680 0.9× 1.3k 1.7× 669 1.6× 219 0.6× 741 2.0× 48 2.1k
Parunag Nishanian United States 20 651 0.8× 996 1.3× 724 1.7× 184 0.5× 468 1.3× 27 1.8k
Peter W. A. Mansell United States 26 529 0.7× 417 0.6× 557 1.3× 210 0.5× 747 2.0× 64 2.3k
Stephen Raffanti United States 25 1.2k 1.6× 711 1.0× 197 0.5× 83 0.2× 508 1.4× 58 1.9k

Countries citing papers authored by Alejandro Vallejo

Since Specialization
Citations

This map shows the geographic impact of Alejandro Vallejo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Vallejo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Vallejo more than expected).

Fields of papers citing papers by Alejandro Vallejo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandro Vallejo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Vallejo. The network helps show where Alejandro Vallejo may publish in the future.

Co-authorship network of co-authors of Alejandro Vallejo

This figure shows the co-authorship network connecting the top 25 collaborators of Alejandro Vallejo. A scholar is included among the top collaborators of Alejandro Vallejo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandro Vallejo. Alejandro Vallejo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Izquierdo, Rebeca, Alejandro Vallejo, Inés Suárez‐García, et al.. (2025). Markers of Inflammation and Immune Dysfunction and Non-AIDS Cancer Risk in Adults With HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes. 99(3). 274–282.
2.
3.
4.
5.
Casado, José L., Pilar Vizcarra, José Manuel del Rey, et al.. (2022). Lost in Translation: Evaluation of Subcutaneous Interferon-β Treatment for SARS-CoV-2 Infection in Real Life. Journal of Clinical Medicine. 11(23). 6952–6952. 1 indexed citations
6.
Abad-Fernández, María, María Jesús Vivancos, Maria Jesús Pérez‐Elías, et al.. (2022). HTLV-2 Enhances CD8+ T Cell-Mediated HIV-1 Inhibition and Reduces HIV-1 Integrated Proviral Load in People Living with HIV-1. Viruses. 14(11). 2472–2472. 3 indexed citations
7.
Gosalbes, María José, Nuria Jiménez‐Hernández, Elena Moreno, et al.. (2022). Interactions among the mycobiome, bacteriome, inflammation, and diet in people living with HIV. Gut Microbes. 14(1). 2089002–2089002. 15 indexed citations
8.
Casado, José L., et al.. (2022). Risk of SARS-CoV-2 Reinfections in a Prospective Inception Cohort Study: Impact of COVID-19 Vaccination. Journal of Clinical Medicine. 11(12). 3352–3352. 1 indexed citations
9.
Vallejo, Alejandro, et al.. (2021). IFN‐γ+ cell response and IFN‐γ release concordance after in vitro SARS‐CoV‐2 stimulation. European Journal of Clinical Investigation. 51(12). e13636–e13636. 9 indexed citations
10.
Casado, José L., et al.. (2021). Expansion of CD56dimCD16neg NK Cell Subset and Increased Inhibitory KIRs in Hospitalized COVID-19 Patients. Viruses. 14(1). 46–46. 15 indexed citations
11.
Vizcarra, Pilar, et al.. (2021). BNT162b2 mRNA COVID-19 vaccine Reactogenicity: The key role of immunity. Vaccine. 39(51). 7367–7374. 13 indexed citations
12.
Vázquez, Esther, Yolanda M. Pacheco, Maria Jesús Pérez‐Elías, et al.. (2020). Risk, Diagnostic and Predictor Factors for Classical Hodgkin Lymphoma in HIV-1-Infected Individuals: Role of Plasma Exosome-Derived miR-20a and miR-21. Journal of Clinical Medicine. 9(3). 760–760. 16 indexed citations
13.
14.
Ruíz-Mateos, Ezequiel, Laura Tarancón‐Díez, Carolina Gutiérrez, et al.. (2019). High CD8 T cell percentage and HCV replication control are common features in HIV-1 controllers and HTLV-2-co-infected patients with a history of injection drug use. Virus Research. 264. 40–44. 6 indexed citations
15.
Vallejo, Alejandro, Begoña Monge‐Maíllo, Carolina Gutiérrez, et al.. (2016). Changes in the immune response after treatment with benznidazole versus no treatment in patients with chronic indeterminate Chagas disease. Acta Tropica. 164. 117–124. 32 indexed citations
16.
Abad-Fernández, María, et al.. (2010). HTLV-2b Among HIV Type 1-Coinfected Injecting Drug Users in Spain. AIDS Research and Human Retroviruses. 27(5). 579–583. 13 indexed citations
17.
Luque, Juan M., Juan Manuel Lozano, Natalia Soriano-Sarabia, et al.. (2008). NK-Associated Regulatory Receptors in a Structured HAART Interruption of HIV-1-Positive Individuals. AIDS Research and Human Retroviruses. 24(8). 1037–1042. 5 indexed citations
18.
Vallejo, Alejandro, Ezequiel Ruíz-Mateos, Sonia Molina‐Pinelo, et al.. (2006). Immunovirologic Characteristics of Human Immunodeficiency Virus-Infected Patients Consisting Mainly of Injecting Drug Users on Highly Active Antiretroviral Treatment with Prolonged Virologic Failure. Viral Immunology. 19(4). 759–767. 8 indexed citations
19.
Toro, Carlos, Berta Rodés, Antonio Aguilera, et al.. (2004). Infecciones por VIH-2 y HTLV-I/II en España. Enfermedades Infecciosas y Microbiología Clínica. 22(3). 177–182. 7 indexed citations
20.
Terrazas, Teresa, et al.. (2003). Análisis fenético de caracteres anatómico-foliares de Trichocentrum y géneros relacionados (Orchidaceae, Oncidiinae). Lankesteriana. 51–53. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Leal Breakdown of academic impact, for papers by Carol Harris Breakdown of academic impact, for papers by Don Smith Breakdown of academic impact, for papers by Angela M. Amedee Breakdown of academic impact, for papers by Jorge Carrillo Breakdown of academic impact, for papers by Raphael B. Stricker Breakdown of academic impact, for papers by Priya Sehgal Breakdown of academic impact, for papers by Parunag Nishanian Breakdown of academic impact, for papers by Peter W. A. Mansell Breakdown of academic impact, for papers by Stephen Raffanti
Rankless by CCL
2026